Key Takeaways
- • Apogem Capital led a minority investment in Family Care Center, a Denver-based outpatient mental health provider backed by Revelstoke.
- • Family Care Center offers therapy, psychiatry, transcranial magnetic stimulation (TMS) and intensive outpatient programs.
- • The company operates more than 50 clinics across five states.
- • The primary source does not disclose the transaction size or valuation.
Summary
Apogem Capital has led a minority investment in Family Care Center, a Denver-based outpatient mental health business backed by Revelstoke, according to a report on the transaction. The company provides a range of outpatient services, including individual and group therapy, psychiatric care, transcranial magnetic stimulation (TMS) and intensive outpatient programs. Family Care Center operates more than 50 clinics across five states.
The source describes the deal as a minority investment, which indicates that Revelstoke retains a controlling or significant stake in the business. The available reporting does not disclose the investment amount, the valuation, or the terms of the transaction. Further details on the capital deployed and the intended use of proceeds, such as clinic expansion or new service lines, were not available in the source material.
The transaction reflects continued private capital interest in outpatient behavioral health, a sector where multi-site providers with diversified service offerings, including neuromodulation therapies such as TMS, have attracted sponsor attention. Full coverage of the transaction is available to registered readers of the original publication.
The source describes the deal as a minority investment, which indicates that Revelstoke retains a controlling or significant stake in the business. The available reporting does not disclose the investment amount, the valuation, or the terms of the transaction. Further details on the capital deployed and the intended use of proceeds, such as clinic expansion or new service lines, were not available in the source material.
The transaction reflects continued private capital interest in outpatient behavioral health, a sector where multi-site providers with diversified service offerings, including neuromodulation therapies such as TMS, have attracted sponsor attention. Full coverage of the transaction is available to registered readers of the original publication.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.